BE739613A - - Google Patents

Info

Publication number
BE739613A
BE739613A BE739613DA BE739613A BE 739613 A BE739613 A BE 739613A BE 739613D A BE739613D A BE 739613DA BE 739613 A BE739613 A BE 739613A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE739613A publication Critical patent/BE739613A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE739613D 1968-10-03 1969-09-30 BE739613A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4704268 1968-10-03
GB266069 1969-01-16

Publications (1)

Publication Number Publication Date
BE739613A true BE739613A (en:Method) 1970-03-02

Family

ID=26237645

Family Applications (1)

Application Number Title Priority Date Filing Date
BE739613D BE739613A (en:Method) 1968-10-03 1969-09-30

Country Status (7)

Country Link
BE (1) BE739613A (en:Method)
CA (1) CA934663A (en:Method)
DE (1) DE1949774A1 (en:Method)
ES (1) ES372150A1 (en:Method)
FR (1) FR2019845A1 (en:Method)
IE (1) IE33333B1 (en:Method)
NL (1) NL6914820A (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE14837T1 (de) * 1981-10-05 1985-08-15 Alec James Coppen Pharmazeutische zusammensetzungen.
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
CA2410966C (en) * 2002-11-01 2005-11-22 Craig J. Hudson Sexual desire and performance enhancement with protein-bound tryptophan

Also Published As

Publication number Publication date
IE33333B1 (en) 1974-05-29
NL6914820A (en:Method) 1970-04-07
DE1949774A1 (de) 1970-05-27
FR2019845A1 (en) 1970-07-10
IE33333L (en) 1970-04-03
FR2019845B1 (en:Method) 1973-01-12
ES372150A1 (es) 1971-12-16
CA934663A (en) 1973-10-02

Similar Documents

Publication Publication Date Title
AU5506869A (en:Method)
AU5184069A (en:Method)
AU6168869A (en:Method)
AU6171569A (en:Method)
FR2019845B1 (en:Method)
AU4811568A (en:Method)
AU3224368A (en:Method)
BE719507A (en:Method)
BE709484A (en:Method)
BE728527A (en:Method)
BE728412A (en:Method)
BE728339A (en:Method)
BE727963A (en:Method)
BE727680A (en:Method)
BE727190A (en:Method)
AU3083868A (en:Method)
BE727044A (en:Method)
BE727004A (en:Method)
BE726959A (en:Method)
BE726720A (en:Method)
BE726486A (en:Method)
BE726369A (en:Method)
BE722491A (en:Method)
BE728768A (en:Method)
BE714711A (en:Method)